Why the study?
Does angiotensin II alter voltage-gated K+ channels in rat arterial smooth muscle cells?
Does angiotensin II alter voltage-gated K+ channels in rat arterial smooth muscle cells?
Angiotensin II inhibits voltage-gated potassium channels in rat arterial smooth muscle via activation of PKC-epsilon and inhibition of PKA.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; leaves open whether ANG II-PKC/PKA signaling modulates arterial tone in vivo.
The vasoconstrictor angiotensin II (ANG II) inhibits several types of K(+) channels. We examined the inhibitory mechanism of ANG II on voltage-gated K(+) (K(V)) currents (I(K(V))) recorded from isolated rat arterial smooth muscle using patch-clamp techniques. Application of 100 nM ANG II accelerated the activation of I(K(V)) but also caused inactivation. These effects were abolished by the AT(1) receptor antagonist losartan. The protein kinase A (PKA) inhibitor Rp-cyclic 3',5'-hydrogen phosphothioate adenosine (100 microM) and an analog of diacylglycerol, 1,2-dioctanyoyl-rac-glycerol (2 microM), caused a significant reduction of I(K(V)). Furthermore, the combination of 5 microM PKA inhibitor peptide 5-24 (PKA-IP) and 100 microM protein kinase C (PKC) inhibitor peptide 19-27 (PKC-IP) prevented the inhibition by ANG II, although neither alone was effective. The ANG II effect seen in the presence of PKA-IP remained during addition of the Ca(2+)-dependent PKC inhibitor Gö6976 (1 microM) but was abolished in the presence of 40 microM PKC-epsilon translocation inhibitor peptide. These results demonstrate that ANG II inhibits K(V) channels through both activation of PKC-epsilon and inhibition of PKA.
No takes yet. Share an insight, caveat, or question.
Hayabuchi et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: